Ambergate Trust
Agricultural biotechnology company Ceres, Inc., based in Thousand Oaks, California, filed an Initial Public Offering prospectus with the U.S. regulators Monday planning to raise up to $100 million and to list on NASDAQ under the symbol CERE.





